Pfizer Secures UK Contract for RSV Vaccine Abrysvo Supply

Replacing GSK, Pfizer Secures Contract to Supply Millions of RSV Vaccine Doses to the UK. According to an edited contract released earlier this month, Pfizer has been selected to supply over 3.5 million doses of its Abrysvo vaccine to elderly individuals in England and Northern Ireland over the next two years, as well as more than 1.4 million doses to pregnant women to protect their infants. The vaccines will begin delivery in July to protect the elderly and newborns before the arrival of the next cold season. (Jiemian)Original Link